AI to Reduce the Interval Cancer Rate of Screening Digital Breast Tomosynthesis
Radiology · 2025
DOI: 10.1148/radiol.241050 ↗Kurz gefasst
Fachartikel in der Zeitschrift Radiology, 2025. Verfasst von Manisha Bahl und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Massachusetts General Hospital, 55 Fruit St, WAC 240, Boston, MA 02114. Hauptthemen laut MEDLINE: Breast Neoplasms, Mammography, Artificial Intelligence. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
The use of a U.S. Food and Drug Administration–cleared artificial intelligence algorithm for lesion detection and diagnosis at screening digital breast tomosynthesis examinations could reduce interval cancers by nearly one-third.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Radiology, Massachusetts General Hospital, 55 Fruit St, WAC 240, Boston, MA 02114.
- Now with Department of Electrical Engineering, Pontificia Universidad Católica de Chile, Santiago, Chile.
ORCID-Profile: Manisha Bahl, Saul Langarica, Leslie R Lamb, Ariel S Kniss, Synho Do
Zitieren
APA
Bahl, M., Langarica, S., Lamb, L. R., Kniss, A. S., & Do, S. (2025). AI to Reduce the Interval Cancer Rate of Screening Digital Breast Tomosynthesis. Radiology. https://doi.org/10.1148/radiol.241050
Vancouver
Bahl M, Langarica S, Lamb LR, Kniss AS, Do S. AI to Reduce the Interval Cancer Rate of Screening Digital Breast Tomosynthesis. Radiology. 2025. doi:10.1148/radiol.241050
BibTeX
@article{Bahl2025,
author = {Bahl, Manisha and Langarica, Saul and Lamb, Leslie R and Kniss, Ariel S and Do, Synho},
title = {AI to Reduce the Interval Cancer Rate of Screening Digital Breast Tomosynthesis},
journal = {Radiology},
year = {2025},
doi = {10.1148/radiol.241050}
}
EUVIMED